{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:13:56Z","timestamp":1792088036106,"version":"4.4.0"},"reference-count":29,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"19","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO"],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>To determine whether the administration of histology-tailored neoadjuvant chemotherapy (HT) was superior to the administration of standard anthracycline plus ifosfamide neoadjuvant chemotherapy (A+I) in high-risk soft tissue sarcoma (STS) of an extremity or the trunk wall.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS AND METHODS<\/jats:title>\n                    <jats:p>This was a randomized, open-label, phase III trial. Patients had localized high-risk STS (grade 3; size, \u2265 5 cm) of an extremity or trunk wall, belonging to one of the following five histologic subtypes: high-grade myxoid liposarcoma (HG-MLPS); leiomyosarcoma (LMS), synovial sarcoma (SS), malignant peripheral nerve sheath tumor (MPNST), and undifferentiated pleomorphic sarcoma (UPS). Patients were randomly assigned in a 1:1 ratio to receive three cycles of A+I or HT. The HT regimens were as follows: trabectedin in HG-MLPS; gemcitabine plus dacarbazine in LMS; high-dose prolonged-infusion ifosfamide in SS; etoposide plus ifosfamide in MPNST; and gemcitabine plus docetaxel in UPS. Primary and secondary end points were disease-free survival (DFS) and overall survival (OS), estimated using the Kaplan-Meier method and compared using Cox models adjusted for treatment and stratification factors. The study is registered at ClinicalTrials.gov (identifier NCT01710176 ).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Between May 2011 and May 2016, 287 patients (UPS: n = 97 [33.8%]; HG-MLPS: n = 65 [22.6%]; SS: n = 70 [24.4%]; MPNST: n = 27 [9.4%]; and LMS: n = 28 [9.8%]) were randomly assigned to either A+I or HT. At the final analysis, with a median follow-up of 52 months, the projected DFS and OS probabilities were 0.55 and 0.47 (log-rank P = .323) and 0.76 and 0.66 (log-rank P = .018) at 60 months in the A+I arm and HT arm, respectively. No treatment-related deaths were observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>In a population of patients with localized high-risk STS, HT was not associated with a better DFS or OS, suggesting that A+I should remain the regimen to choose whenever neoadjuvant chemotherapy is used in patients with high-risk STS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/jco.19.03289","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T16:00:22Z","timestamp":1589817622000},"page":"2178-2186","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":235,"title":["Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups"],"prefix":"10.1200","volume":"38","author":[{"given":"Alessandro","family":"Gronchi","sequence":"first","affiliation":[{"name":"Department of Surgery, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale dei Tumori, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Palmerini","sequence":"additional","affiliation":[{"name":"Chemotherapy Unit, IRCCS, Istituto Ortopedico Rizzoli, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Quagliuolo","sequence":"additional","affiliation":[{"name":"Department of Surgery, Istituto Clinico Humanitas, Rozzano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Martin Broto","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, University Hospital Virgen del Rocio, Sevilla, Spain"},{"name":"Institute of Biomedicine of Sevilla, University of Sevilla, Sevilla, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lopez Pousa","sequence":"additional","affiliation":[{"name":"Department of Cancer Medicine, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Grignani","sequence":"additional","affiliation":[{"name":"Department of Cancer Medicine, Fondazione del Piemonte per l'Oncologia, IRCCS, Candiolo, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Brunello","sequence":"additional","affiliation":[{"name":"Department of Oncology, Medical Oncology 1 Unit, Istituto Oncologico Veneto, IRCCS, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Blay","sequence":"additional","affiliation":[{"name":"Department of Cancer Medicine, Centre L\u00e9on B\u00e9rard Cancer Center, Lyon, France"},{"name":"Universit\u00e9 Claude Beranrd Lyon I, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Tendero","sequence":"additional","affiliation":[{"name":"Department of Surgery, Hospital Universitari Son Espases, Palma de Mallorca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Diaz Beveridge","sequence":"additional","affiliation":[{"name":"Department of Cancer Medicine, Hospital Universitari i Polit\u00e8cnic La Fe, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Ferraresi","sequence":"additional","affiliation":[{"name":"Department of Cancer Medicine, Istituto Regina Elena, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Lugowska","sequence":"additional","affiliation":[{"name":"Department of Soft Tissue\/Bone Sarcoma and Melanoma, Centrum Onkologii, Instytutim, Marii Sklodowskiej-Curie, Warszawa, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico Franco","family":"Merlo","sequence":"additional","affiliation":[{"name":"Research and Statistics Infrastructure, Azienda Unit\u00e0 Sanitaria Locale, IRCCS, Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Fontana","sequence":"additional","affiliation":[{"name":"Clinical Trial Center and Department of Epidemiology, IRCCS Azienda Ospedaliera Universitaria San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Marchesi","sequence":"additional","affiliation":[{"name":"Clinical Trial Center, Italian Sarcoma Group, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Braglia","sequence":"additional","affiliation":[{"name":"Research and Statistics Infrastructure, Azienda Unit\u00e0 Sanitaria Locale, IRCCS, Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide Maria","family":"Donati","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Oncology, Istituto Ortopedico Rizzoli, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Palassini","sequence":"additional","affiliation":[{"name":"Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Oncology, Istituto Ortopedico Rizzoli, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Marrari","sequence":"additional","affiliation":[{"name":"Department of Cancer Medicine, Istituto Clinico Humanitas, Rozzano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Morosi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Stacchiotti","sequence":"additional","affiliation":[{"name":"Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bagu\u00e9","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Michel","family":"Coindre","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institut Bergoni\u00e9, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Paolo","family":"Dei Tos","sequence":"additional","affiliation":[{"name":"Department of Pathology, Treviso General Hospital Treviso, Padova, Italy"},{"name":"University of Padua, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Picci","sequence":"additional","affiliation":[{"name":"Laboratory of Oncologic Research, Istituto Ortopedico Rizzoli, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bruzzi","sequence":"additional","affiliation":[{"name":"Clinical Trial Center and Department of Epidemiology, IRCCS Azienda Ospedaliera Universitaria San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo Giovanni","family":"Casali","sequence":"additional","affiliation":[{"name":"Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"},{"name":"Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.09.028"},{"key":"B2","volume-title":"WHO Classification of Tumours of Soft Tissue and Bone","author":"Fletcher CDM","year":"2013"},{"key":"B3","author":"Sarcoma Meta-Analysis Collaboration","year":"1997","journal-title":"Adjuvant chemotherapy for localisedresectable soft-tissue sarcoma of adults: meta-analysis of individual data."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23592"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy096"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.5.1238"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1159\/000073366"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw430"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0843"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.6107"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.4117"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70175-4"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2013.31.15_suppl.10522"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30334-0"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910330108"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.3049"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2512081403"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27624"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"B21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"Cox DR","year":"1972","journal-title":"J R Stat Soc B"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/1740774506073467"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00010-3"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70346-7"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.12.009"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.9394"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds501"},{"key":"B28","author":"D\u2019Ambrosio L","journal-title":"Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2019.03.007"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.19.03289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T19:52:13Z","timestamp":1722887533000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.19.03289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":29,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2020,7,1]]}},"alternative-id":["10.1200\/JCO.19.03289"],"URL":"https:\/\/doi.org\/10.1200\/jco.19.03289","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737974469.793581001","asserted-by":"object"}]},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,1]]},"assertion":[{"value":"2020-03-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}